Compare ADMA Biologics Inc (ADMA) vs CubeSmart (CUBE) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ADMA Biologics Inc vs CubeSmart — how do they compare? ADMA Biologics Inc trades at $9.06 (market cap $2.13B), while CubeSmart trades at $39.9 (market cap $9.26B). The key difference: CubeSmart is far larger — about 4.3× ADMA Biologics Inc's market cap, and CubeSmart pays a 5.19% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | CUBE | |
|---|---|---|
Market Cap | $2.13B | $9.26B |
Sector | Health | Real Estate |
52-Week High | $20.38 | $42.60 |
52-Week Low | $7.60 | $35.36 |
Enterprise Value | $2.20B | $12.75B |
Dividend Yield | — | 5.19% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About CubeSmart
CubeSmart is a real estate investment trust that acquires, owns, and manages self-storage facilities throughout the United States. The company's real estate portfolio is composed of buildings with numerous enclosed storage areas for both residential and commercial customers to rent mainly on a month-by-month basis. Most of CubeSmart's facilities are located in Florida, Texas, California, New York, and Illinois. Cumulatively, these states account for both the majority of the square footage in the company's real estate portfolio and the majority of its revenue. CubeSmart derives nearly all of its revenue from rental income from tenants utilizing its storage facilities.
Read more on CUBE →
